by Amanda McDavid | Apr 25, 2025 | Viewpoints
This week, I draw your attention to the notice in the Newsletter regarding Glenmark Pharmaceuticals, Inc. and the issuance of a recent FDA Warning Letter stopping importation and recall of 39 different generic products manufactured at the Glenmark facility in India....
by Amanda McDavid | Apr 18, 2025 | Viewpoints
The Hidden Math Behind Veterinary Rx Sales: A Tale of Two Channels How do margins really stack-up for pet Rx products in-clinic vs. clinic online store sales? Let’s crunch the numbers: A 30-day supply of Carprofen priced at $50 (wholesale $30) appears to offer a...
by Amanda McDavid | Apr 11, 2025 | Viewpoints
One can say that we certainly live in interesting times! The US administration believes that a “rebalancing” of trade conditions is required, and part of the rebalancing involves tariffs. This has sparked a huge debate and also a panic in the stock markets- resulting...
by Amanda McDavid | Apr 4, 2025 | Viewpoints
Coloradoans recently voted in favor of a Veterinary Professional Associate (VPA) position, with responsibility and authorization between a licensed technician and a veterinarian. I attended one of the liveliest panel discussions on this very topic during a recent...
by Amanda McDavid | Mar 28, 2025 | Viewpoints
In last week’s viewpoint, Lynn Fondon discussed how the veterinarian profession needs to look beyond price and fee increases to maintain revenue growth. I totally agree. Volume increases is critical to drive growth. This not only holds true for veterinarians but...
by Amanda McDavid | Mar 21, 2025 | Viewpoints
This week’s news items included a white paper from data analytics company Vetsource that indicates that vet visits are down, and revenue growth at clinics is slowing. The profession benefitted from a surge in demand for veterinary care during the pandemic, as well as...